Condition
Relapse/Recurrence clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Relapse/Recurrence clinical trials that are recruiting, at sites in 11 countries (most in China (2), United States (1), Czechia (1)). By phase: Phase 2 (2), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 11Countries
Newest Relapse/Recurrence clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Mindfulness-Based Relapse Prevention for Peer Workers | — | Austin, Texas | Recruiting | Aug 3, 2026 |
| Bugitinib with venetoclax and cytarabine for relapsed or refractory acute myeloid leukemia | Phase 2 | Shenzhen, Guangdong | Recruiting | May 1, 2026 |
| Comparing high and low intensity therapies for relapsed or refractory acute myeloid leukemia | Phase 3 | Brno and 50 other locations | Recruiting | Dec 3, 2024 |
| Using Avapritinib to treat relapsed or refractory pediatric CBF-AML with KIT mutation | Phase 2 | Hefei, Anhui and 11 other locations | Recruiting | Mar 19, 2024 |
| Predicting early relapse in lung cancer patients after surgery | — | Taoyuan City | Recruiting | Feb 16, 2024 |
All recruiting trials (5)
-
Mindfulness-Based Relapse Prevention for Peer Workers
We’re testing whether Mindfulness-Based Relapse Prevention can help substance-use peer workers cut down on use and burnout compared with usual referrals to a 12-step program.
-
Bugitinib with venetoclax and cytarabine for relapsed or refractory acute myeloid leukemia
This trial tests whether the three-drug combination of bugitinib, venetoclax, and cytarabine can clear minimal residual disease in adults with relapsed or refractory AML.
-
Comparing high and low intensity therapies for relapsed or refractory acute myeloid leukemia
This study is testing whether high-intensity chemotherapy works better than low-intensity treatments for people with relapsed or refractory acute myeloid leukemia.
-
Using Avapritinib to treat relapsed or refractory pediatric CBF-AML with KIT mutation
This study is testing if a new drug called avapritinib can help children with a specific type of leukemia that keeps coming back and has a certain mutation, to see if it works better than the treatments they currently have.
-
Predicting early relapse in lung cancer patients after surgery
This study is testing a new way to predict early relapse in lung cancer patients after surgery by looking at changes in their tumor cells and seeing if giving them chemotherapy helps improve their outcomes.
Related topics
Quick answers
How many Relapse/Recurrence clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 11 countries. The most sites are in China (2 trials), United States (1 trial), Czechia (1 trial), Germany (1 trial), Italy (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.